Cadila is the latest to get approval from DGCI for COVID vaccine. This comes after Bharat Biotech's Covaxin. The latest vaccine has been indigenously developed by Zydus Cadila Healthcare based out of Gujarat. Cadila has got the nod from the Drugs Controller General of India or DCGI for human clinical trials.

The assent for human trials was given after the company submitted data of clinical trial on animals to the DCGI, in which the vaccine candidate was found to be successful with respect to safety and immunogenicity. Human trials is the next and last stage after which the company will be allowed to commercializes and produce the vaccines.